C10orf113: A Potential Drug Target and Biomarker (G387638)

Target Name: C10orf113

NCBI ID: G387638

C10orf113

Other Name(s): Putative uncharacterized protein C10orf113 (isoform 1) | bA165O3.1 | C10orf113 variant 1 | Chromosome 10 open reading frame 113, transcript variant 1 | putative uncharacterized protein C10orf113

C10orf113: A Potential Drug Target and Biomarker

C10orf113 is a protein that has been identified as a potential drug target and biomarker. It is a member of the C10ORF gene family, which encodes for small proteins involved in various cellular processes. C10orf113 is unique due to its missense mutation, which has led to its elongation from its original 113 amino acid residues to 114 residues. This extended amino acid sequence is thought to have implications for its function and may be a potential drug target.

C10orf113 and its function

The function of C10orf113 is still being explored, but research has suggested that it may be involved in various cellular processes, including cell signaling, inflammation, and stress response. C10orf113 has been shown to be involved in the regulation of cell adhesion, migration, and invasion, as well as in the production of pro-inflammatory cytokines.

C10orf113 as a drug target

C10orf113 has been identified as a potential drug target due to its unique structure and the various functions it is thought to have. One of the potential strategies for targeting C10orf113 is to use small molecules that can modulate its activity. This approach has been used to identify several potential drug candidates, including inhibitors of C10orf113's activity in cell signaling pathways.

Another approach to targeting C10orf113 is to use antibodies that can specifically recognize and target its missense mutation. This approach has been used to generate antibodies that can bind to C10orf113 and prevent it from interacting with its target protein, potentially leading to a reduction in the activity of the target protein.

C10orf113 as a biomarker

In addition to its potential as a drug target, C10orf113 has also been identified as a potential biomarker for various diseases. The missense mutation that causes its elongation has been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The elongation of C10orf113 may also be a potential biomarker for certain diseases, as the increased size of the protein may be indicative of its accumulation in affected cells. This approach has been used to identify C10orf113 as a potential biomarker for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Conclusion

C10orf113 is a unique protein that has been identified as a potential drug target and biomarker. Its unique structure and various functions make it an attractive target for small molecules and antibodies. Further research is needed to fully understand the role of C10orf113 in cellular processes and its potential as a drug and biomarker.

Protein Name: Chromosome 10 Open Reading Frame 113, Transcript Variant 1

The "C10orf113 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C10orf113 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets